Cimzia® (certolizumab pegol) – New indication
May 29, 2018 - UCB announced the FDA approval of Cimzia (certolizumab pegol), for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
Download PDF
